US Stock MarketDetailed Quotes

OSCR Oscar Health

Watchlist
  • 16.850
  • +0.870+5.44%
Close Nov 25 16:00 ET
  • 16.890
  • +0.040+0.24%
Post 20:01 ET
4.17BMarket Cap-842500P/E (TTM)

Oscar Health Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating cash flow (Indirect Method)
Cash flow from continuing operating activities
56.48%-500.14M
200.35%497.15M
52.96%634.36M
-171.56%-272.16M
96.09%296.87M
-109.58%-1.15B
-22.82%165.52M
-26.32%414.72M
309.28%380.35M
339.09%151.39M
Net income from continuing operations
17.22%-54.39M
465.07%56.31M
547.87%177.48M
55.61%-270.59M
33.86%-149.84M
66.05%-65.7M
86.24%-15.43M
48.75%-39.63M
-6.67%-609.55M
-14.57%-226.56M
Operating gains losses
----
----
----
-94.51%70K
--0
-91.98%61K
54.05%-34K
-92.61%43K
709.57%1.27M
-91.53%5K
Deferred tax
-272.46%-119K
-37.80%130K
56.83%-79K
135.15%58K
78.36%-37K
3,350.00%69K
5,125.00%209K
---183K
-63.37%-165K
-56.88%-171K
Other non cash items
-113.51%-300K
-115.53%-200K
-111.78%-1M
857.56%28.61M
--16.61M
--2.22M
--1.29M
341.78%8.49M
-85.19%2.99M
----
Change in working capital
57.40%-475.6M
182.75%410.39M
14.22%430.24M
-122.47%-192.09M
17.10%402.57M
-186.73%-1.12B
-50.73%145.14M
-37.85%376.69M
245.18%855M
74.07%343.77M
-Change in receivables
12.98%74.62M
-181.88%-63.71M
-132.84%-152.49M
215.44%636.23M
135.93%28.03M
157.32%66.05M
144.37%77.81M
354.38%464.34M
-876.83%-551.15M
-155.72%-78.01M
-Change in loss and loss adjustment expense reserves
90.91%104.5M
103.95%3.88M
1,627.08%282.36M
-93.34%28.26M
195.70%55.54M
-52.50%54.74M
-182.52%-98.37M
-93.40%16.35M
110.32%424.15M
-456.97%-58.03M
-Change in payables and accrued expense
46.78%-657.31M
200.63%483.95M
428.80%308.47M
-185.35%-856.36M
-34.36%311.64M
-216.74%-1.24B
-57.02%160.98M
-117.25%-93.82M
2,501.64%1B
99.56%474.79M
-Change in unearned premiums
200.86%4.71M
-540.64%-7.02M
67.86%-1.82M
45.36%-11.52M
98.74%-87K
-14.11%-4.67M
83.27%-1.1M
-59.54%-5.66M
59.61%-21.08M
67.68%-6.89M
-Change in other current assets
-183.05%-2.13M
-215.40%-6.72M
-38.86%-6.29M
4,753.09%11.31M
-37.45%7.45M
-45.15%2.56M
133.68%5.82M
-1,094.73%-4.53M
97.85%-243K
344.93%11.92M
Cash from discontinued operating activities
Operating cash flow
56.48%-500.14M
200.35%497.15M
52.96%634.36M
-171.56%-272.16M
96.09%296.87M
-109.58%-1.15B
-22.82%165.52M
-26.32%414.72M
309.28%380.35M
339.09%151.39M
Investing cash flow
Cash flow from continuing investing activities
-356.44%-577.77M
-1,188.04%-477.63M
-321.82%-300.59M
354.81%577.19M
124.41%172.48M
-24.59%225.3M
-44.13%43.9M
31.80%135.51M
70.75%-226.52M
-3,462.43%-706.68M
Net investment purchase and sale
-347.75%-572.7M
-1,041.08%-470.89M
-306.64%-295.27M
404.62%605.04M
125.88%180.96M
-24.92%231.16M
-40.56%50.04M
31.76%142.89M
73.70%-198.62M
-4,358.38%-699.12M
Net PPE purchase and sale
-16.78%-7.57M
-34.63%-7.56M
19.37%-5.95M
11.84%-25.58M
14.42%-6.1M
32.63%-6.48M
6.66%-5.62M
-18.12%-7.38M
-12.08%-29.01M
1.05%-7.13M
Net other investing changes
300.48%2.49M
--825K
--626K
-304.03%-2.28M
-450.23%-2.38M
18.48%622K
----
----
-83.28%1.12M
-114.16%-432K
Cash from discontinued investing activities
Investing cash flow
-356.44%-577.77M
-1,188.04%-477.63M
-321.82%-300.59M
354.81%577.19M
124.41%172.48M
-24.59%225.3M
-44.13%43.9M
31.80%135.51M
70.75%-226.52M
-3,462.43%-706.68M
Financing cash flow
Cash flow from continuing financing activities
700.00%18.56M
633.12%18.7M
5,297.04%27.31M
-97.86%6.45M
102.85%1.07M
448.46%2.32M
84.19%2.55M
-99.83%506K
-75.69%301.11M
-95.94%527K
Net issuance payments of debt
----
----
----
--0
----
----
----
----
299.12%305M
--0
Net common stock issuance
----
----
----
--0
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
6,086.67%18.56M
633.12%18.7M
77,925.71%27.31M
204.54%3.96M
21,300.00%1.07M
-18.92%300K
600.82%2.55M
-93.75%35K
-97.79%1.3M
-99.91%5K
Net other financing charges
----
----
----
147.99%2.49M
-100.19%-1K
3,711.32%2.02M
--0
106.94%471K
65.89%-5.19M
-92.78%522K
Cash from discontinued financing activities
Financing cash flow
700.00%18.56M
633.12%18.7M
5,297.04%27.31M
-97.86%6.45M
102.85%1.07M
448.46%2.32M
84.19%2.55M
-99.83%506K
-75.69%301.11M
-95.94%527K
Net cash flow
Beginning cash position
-2.22%2.29B
5.72%2.25B
19.71%1.89B
40.42%1.58B
-33.42%1.42B
-1.73%2.34B
1.97%2.13B
40.42%1.58B
33.50%1.13B
94.48%2.14B
Current changes in cash
-14.94%-1.06B
-81.97%38.23M
-34.44%361.08M
-31.54%311.47M
184.80%470.41M
-269.89%-921.64M
-28.01%211.97M
-42.90%550.73M
61.07%454.94M
-2,108.90%-554.76M
End cash position
-13.34%1.23B
-2.22%2.29B
5.72%2.25B
19.71%1.89B
19.71%1.89B
-33.42%1.42B
-1.73%2.34B
1.97%2.13B
40.42%1.58B
40.42%1.58B
Free cash flow
56.07%-507.71M
206.17%489.59M
54.27%628.41M
-184.74%-297.74M
101.55%290.77M
-107.13%-1.16B
-23.29%159.91M
-26.82%407.34M
269.21%351.34M
428.96%144.26M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating cash flow (Indirect Method)
Cash flow from continuing operating activities 56.48%-500.14M200.35%497.15M52.96%634.36M-171.56%-272.16M96.09%296.87M-109.58%-1.15B-22.82%165.52M-26.32%414.72M309.28%380.35M339.09%151.39M
Net income from continuing operations 17.22%-54.39M465.07%56.31M547.87%177.48M55.61%-270.59M33.86%-149.84M66.05%-65.7M86.24%-15.43M48.75%-39.63M-6.67%-609.55M-14.57%-226.56M
Operating gains losses -------------94.51%70K--0-91.98%61K54.05%-34K-92.61%43K709.57%1.27M-91.53%5K
Deferred tax -272.46%-119K-37.80%130K56.83%-79K135.15%58K78.36%-37K3,350.00%69K5,125.00%209K---183K-63.37%-165K-56.88%-171K
Other non cash items -113.51%-300K-115.53%-200K-111.78%-1M857.56%28.61M--16.61M--2.22M--1.29M341.78%8.49M-85.19%2.99M----
Change in working capital 57.40%-475.6M182.75%410.39M14.22%430.24M-122.47%-192.09M17.10%402.57M-186.73%-1.12B-50.73%145.14M-37.85%376.69M245.18%855M74.07%343.77M
-Change in receivables 12.98%74.62M-181.88%-63.71M-132.84%-152.49M215.44%636.23M135.93%28.03M157.32%66.05M144.37%77.81M354.38%464.34M-876.83%-551.15M-155.72%-78.01M
-Change in loss and loss adjustment expense reserves 90.91%104.5M103.95%3.88M1,627.08%282.36M-93.34%28.26M195.70%55.54M-52.50%54.74M-182.52%-98.37M-93.40%16.35M110.32%424.15M-456.97%-58.03M
-Change in payables and accrued expense 46.78%-657.31M200.63%483.95M428.80%308.47M-185.35%-856.36M-34.36%311.64M-216.74%-1.24B-57.02%160.98M-117.25%-93.82M2,501.64%1B99.56%474.79M
-Change in unearned premiums 200.86%4.71M-540.64%-7.02M67.86%-1.82M45.36%-11.52M98.74%-87K-14.11%-4.67M83.27%-1.1M-59.54%-5.66M59.61%-21.08M67.68%-6.89M
-Change in other current assets -183.05%-2.13M-215.40%-6.72M-38.86%-6.29M4,753.09%11.31M-37.45%7.45M-45.15%2.56M133.68%5.82M-1,094.73%-4.53M97.85%-243K344.93%11.92M
Cash from discontinued operating activities
Operating cash flow 56.48%-500.14M200.35%497.15M52.96%634.36M-171.56%-272.16M96.09%296.87M-109.58%-1.15B-22.82%165.52M-26.32%414.72M309.28%380.35M339.09%151.39M
Investing cash flow
Cash flow from continuing investing activities -356.44%-577.77M-1,188.04%-477.63M-321.82%-300.59M354.81%577.19M124.41%172.48M-24.59%225.3M-44.13%43.9M31.80%135.51M70.75%-226.52M-3,462.43%-706.68M
Net investment purchase and sale -347.75%-572.7M-1,041.08%-470.89M-306.64%-295.27M404.62%605.04M125.88%180.96M-24.92%231.16M-40.56%50.04M31.76%142.89M73.70%-198.62M-4,358.38%-699.12M
Net PPE purchase and sale -16.78%-7.57M-34.63%-7.56M19.37%-5.95M11.84%-25.58M14.42%-6.1M32.63%-6.48M6.66%-5.62M-18.12%-7.38M-12.08%-29.01M1.05%-7.13M
Net other investing changes 300.48%2.49M--825K--626K-304.03%-2.28M-450.23%-2.38M18.48%622K---------83.28%1.12M-114.16%-432K
Cash from discontinued investing activities
Investing cash flow -356.44%-577.77M-1,188.04%-477.63M-321.82%-300.59M354.81%577.19M124.41%172.48M-24.59%225.3M-44.13%43.9M31.80%135.51M70.75%-226.52M-3,462.43%-706.68M
Financing cash flow
Cash flow from continuing financing activities 700.00%18.56M633.12%18.7M5,297.04%27.31M-97.86%6.45M102.85%1.07M448.46%2.32M84.19%2.55M-99.83%506K-75.69%301.11M-95.94%527K
Net issuance payments of debt --------------0----------------299.12%305M--0
Net common stock issuance --------------0------------------0----
Proceeds from stock option exercised by employees 6,086.67%18.56M633.12%18.7M77,925.71%27.31M204.54%3.96M21,300.00%1.07M-18.92%300K600.82%2.55M-93.75%35K-97.79%1.3M-99.91%5K
Net other financing charges ------------147.99%2.49M-100.19%-1K3,711.32%2.02M--0106.94%471K65.89%-5.19M-92.78%522K
Cash from discontinued financing activities
Financing cash flow 700.00%18.56M633.12%18.7M5,297.04%27.31M-97.86%6.45M102.85%1.07M448.46%2.32M84.19%2.55M-99.83%506K-75.69%301.11M-95.94%527K
Net cash flow
Beginning cash position -2.22%2.29B5.72%2.25B19.71%1.89B40.42%1.58B-33.42%1.42B-1.73%2.34B1.97%2.13B40.42%1.58B33.50%1.13B94.48%2.14B
Current changes in cash -14.94%-1.06B-81.97%38.23M-34.44%361.08M-31.54%311.47M184.80%470.41M-269.89%-921.64M-28.01%211.97M-42.90%550.73M61.07%454.94M-2,108.90%-554.76M
End cash position -13.34%1.23B-2.22%2.29B5.72%2.25B19.71%1.89B19.71%1.89B-33.42%1.42B-1.73%2.34B1.97%2.13B40.42%1.58B40.42%1.58B
Free cash flow 56.07%-507.71M206.17%489.59M54.27%628.41M-184.74%-297.74M101.55%290.77M-107.13%-1.16B-23.29%159.91M-26.82%407.34M269.21%351.34M428.96%144.26M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data